Welcome to The Oregon Society of Medical Oncology (OSMO)

 

OSMO is preparing for the Fall 2014 Oncology Conference on Saturday November 1, 2014 at the NINES Hotel in Portland, Oregon. For more information and to register please visit the events page.

OSMO is also gearing up for our Board of Directors elections for the term of 2015-2017. A call for nominations will be sent at the fall meeting. This is a great opportunity for all practicing oncologists who are interested in gaining more knowledge about critical issues and having a platform for your issues to be heard both locally and nationally. Please contact Liz Cleland osmoLIZ@comcast.net for the criteria to be added to the ballot for a board of director position.

Join our efforts to improve cancer care both now and in the future. ´╗┐´╗┐Cancer care is constantly evolving. OSMO remains a committed advocate for the professionals who treat this challenging illness in these tumultuous times. Take an active role in your oncology society and attend the fall and spring meetings.

Sincerely, Sean T. Hehn, MD
OSMO President

 

 

Major benefits of your membership fee include the following:

  • Representation on the ASCO Clinical Practice Committee and other major national initiatives of importance to oncology
  • Representation at the state level on issues of significance to the oncology community
  • Representation of our interests to other physician groups
  • Representation and advocacy to insurance carriers in the state for reimbursement and coverage issues of concern to oncologists

Your support through membership is critical to the continued advancement of OSMO interests: To identify and work to improve oncology practice issues that adversely affect patient access to cancer care; to act as a patient advocate to ensure that patients have access to the best available care; to support and encourage clinical research against cancer.

 

Regularly Monitor the OSMO Website for:

  • OSMO meetings & events
  • Legislative updates
  • Billing & reimbursement updates
  • Resources & tools
  • Oncology news
  • Newsletter

Diamond Partners See All

  • Amgen
  • Astellas Pharma US
  • Bayer
  • Celgene
  • Lilly
  • Genetech
  • Millennium
  • Myriad
  • Novartis Oncology
  • Onyx Pharmaceuticals/
  • Pfizer Oncology
  • Teva